TSTstarr + for Treatment of Severe Prolapsed Hemorrhoids --- a Multi-center Randomized Controlled Clinical Trail

NCT02295592 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 780

Last updated 2014-11-20

No results posted yet for this study

Summary

TSTstarr+ in the treatment of severe hemorrhoids prolapse--A multi center randomized controlled clinical trial.The aim of this stuy is to compare the first year hemorrhoids recurrence rate of TSTstarr+ and PPH in the treatment of severe hemorrhoids.

Conditions

Interventions

PROCEDURE

TSTstarr+

TSTstarr+ : a kind of modified STARR(stapled transanal rectal resection ) operation, compared to the traditional STARR operation, it does not need two staplers but with a larger diameter stapler, " +" means better . Patients in group A with severe prolapsed hemorrhoids will undergo TSTstarr+ operation .

PROCEDURE

PPH

PPH is short fo procedure for prolapsed hemorrhoids .Patients in group B with severe prolapsed hemorrhoids will undergo PPH operation.

Sponsors & Collaborators

  • Suzhou Touchstone International Medical Science Co.,Ltd.

    collaborator UNKNOWN
  • Chengdu Anorectal Hospital

    collaborator UNKNOWN
  • Wuhan University

    collaborator OTHER
  • Fujian Provincial Hospital

    collaborator OTHER
  • First Affiliated Hospital of Fujian Medical University

    collaborator OTHER
  • Nanhai Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Changshu Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Xuzhou Central Hospital

    collaborator OTHER
  • First Affiliated Hospital of Xinjiang Medical University

    collaborator OTHER
  • Shenyang Anorectal Hospital

    collaborator OTHER
  • Wulumuqi General Hospital of Lanzhou Military Command

    collaborator OTHER
  • The First Affiliated Hospital of Guangxi traditional Chinese Medicine University

    collaborator UNKNOWN
  • Xiyuan Hospital of China Academy of Chinese Medical Sciences

    collaborator OTHER
  • Sixth Affiliated Hospital, Sun Yat-sen University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2016-04-30
Completion
2016-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02295592 on ClinicalTrials.gov